Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 94

1.

HER Family Protein Expression in a Greek Population with Gastric Cancer. A Retrospective Hellenic Cooperative Oncology Group Study.

Makatsoris T, Tsamandas AC, Strimpakos A, Alexopoulou Z, Dionysopoulos D, Pervana S, Konstantara A, Papakostas P, Samantas E, Rallis G, Dimou A, Pentheroudakis G, Papaparaskeva K, Psyrri A, Kalogeras KT, Syrigos K, Scopa CD, Fountzilas G.

Anticancer Res. 2016 Apr;36(4):1581-90.

PMID:
27069134
2.

Significance of PIK3CA Mutations in Patients with Early Breast Cancer Treated with Adjuvant Chemotherapy: A Hellenic Cooperative Oncology Group (HeCOG) Study.

Papaxoinis G, Kotoula V, Alexopoulou Z, Kalogeras KT, Zagouri F, Timotheadou E, Gogas H, Pentheroudakis G, Christodoulou C, Koutras A, Bafaloukos D, Aravantinos G, Papakostas P, Charalambous E, Papadopoulou K, Varthalitis I, Efstratiou I, Zaramboukas T, Patsea H, Scopa CD, Skondra M, Kosmidis P, Pectasides D, Fountzilas G.

PLoS One. 2015 Oct 9;10(10):e0140293. doi: 10.1371/journal.pone.0140293. eCollection 2015.

3.

Expression of the microRNA regulators Drosha, Dicer and Ago2 in non-small cell lung carcinomas.

Prodromaki E, Korpetinou A, Giannopoulou E, Vlotinou E, Chatziathanasiadou Μ, Papachristou NI, Scopa CD, Papadaki H, Kalofonos HP, Papachristou DJ.

Cell Oncol (Dordr). 2015 Aug;38(4):307-17. doi: 10.1007/s13402-015-0231-y. Epub 2015 Jul 31.

PMID:
26227789
4.

Prognostic Significance of VEGFC and VEGFR1 mRNA Expression According to HER2 Status in Breast Cancer: A Study of Primary Tumors from Patients with High-risk Early Breast Cancer Participating in a Randomized Hellenic Cooperative Oncology Group Trial.

Linardou H, Kalogeras KT, Kronenwett R, Alexopoulou Z, Wirtz RM, Zagouri F, Scopa CD, Gogas H, Petraki K, Christodoulou C, Pavlakis K, Koutras AK, Samantas E, Patsea H, Pectasides D, Bafaloukos D, Fountzilas G.

Anticancer Res. 2015 Jul;35(7):4023-36.

PMID:
26124351
5.

Randomized phase III clinical trial comparing the combination of capecitabine and oxaliplatin (CAPOX) with the combination of 5-fluorouracil, leucovorin and oxaliplatin (modified FOLFOX6) as adjuvant therapy in patients with operated high-risk stage II or stage III colorectal cancer.

Pectasides D, Karavasilis V, Papaxoinis G, Gourgioti G, Makatsoris T, Raptou G, Vrettou E, Sgouros J, Samantas E, Basdanis G, Papakostas P, Bafaloukos D, Kotoula V, Kalofonos HP, Scopa CD, Pentheroudakis G, Fountzilas G.

BMC Cancer. 2015 May 10;15:384. doi: 10.1186/s12885-015-1406-7.

6.

Expression of phosphorylated Akt, mTOR and MAPK in type I endometrial carcinoma: clinical significance.

Kourea HP, Nikolaou M, Tzelepi V, Adonakis G, Kardamakis D, Tsapanos V, Scopa CD, Kalofonos C, Decavalas G.

Anticancer Res. 2015 Apr;35(4):2321-31.

PMID:
25862896
7.

Impact of tumor angiogenic profile on the outcome of patients with metastatic breast carcinoma treated with weekly docetaxel. A Hellenic Cooperative Oncology Group (HeCOG) study.

Kourea HP, Kotoula V, Koutras A, Alexopoulou Z, Papaspirou I, Skarlos DV, Efstratiou I, Bobos M, Zagouri F, Papakostas P, Pectasides D, Chrisafi S, Varthalitis I, Aravantinos G, Kosmidis P, Bafaloukos D, Scopa CD, Fountzilas G.

Histol Histopathol. 2015 Sep;30(9):1129-41. doi: 10.14670/HH-11-612. Epub 2015 Mar 25.

PMID:
25807307
8.

Targeted pathways in breast cancer: molecular and protein markers guiding therapeutic decisions.

Kourea HP, Zolota V, Scopa CD.

Curr Mol Pharmacol. 2014;7(1):4-21. Review.

PMID:
25563853
9.

Expression of claudins-1, -4, -5, -7 and occludin in hepatocellular carcinoma and their relation with classic clinicopathological features and patients' survival.

Bouchagier KA, Assimakopoulos SF, Karavias DD, Maroulis I, Tzelepi V, Kalofonos H, Karavias DD, Kardamakis D, Scopa CD, Tsamandas AC.

In Vivo. 2014 May-Jun;28(3):315-26.

PMID:
24815833
10.

The prognostic role of preoperative serum CA 125 levels in patients with endometrial carcinoma.

Nikolaou M, Kourea HP, Tzelepi V, Adonakis G, Scopa CD, Tsapanos V, Kardamakis D, Kalofonos C, Decavalas G.

J BUON. 2014 Jan-Mar;19(1):198-202.

11.

Prognostic significance of ESR1 gene amplification, mRNA/protein expression and functional profiles in high-risk early breast cancer: a translational study of the Hellenic Cooperative Oncology Group (HeCOG).

Pentheroudakis G, Kotoula V, Eleftheraki AG, Tsolaki E, Wirtz RM, Kalogeras KT, Batistatou A, Bobos M, Dimopoulos MA, Timotheadou E, Gogas H, Christodoulou C, Papadopoulou K, Efstratiou I, Scopa CD, Papaspyrou I, Vlachodimitropoulos D, Linardou H, Samantas E, Pectasides D, Pavlidis N, Fountzilas G.

PLoS One. 2013 Jul 29;8(7):e70634. doi: 10.1371/journal.pone.0070634. Print 2013.

12.

Nrf2 is commonly activated in papillary thyroid carcinoma, and it controls antioxidant transcriptional responses and viability of cancer cells.

Ziros PG, Manolakou SD, Habeos IG, Lilis I, Chartoumpekis DV, Koika V, Soares P, Kyriazopoulou VE, Scopa CD, Papachristou DJ, Sykiotis GP.

J Clin Endocrinol Metab. 2013 Aug;98(8):E1422-7. doi: 10.1210/jc.2013-1510. Epub 2013 Jun 13.

PMID:
23766517
13.

Intestinal mucosal proliferation, apoptosis and oxidative stress in patients with liver cirrhosis.

Assimakopoulos SF, Tsamandas AC, Tsiaoussis GI, Karatza E, Zisimopoulos D, Maroulis I, Kontogeorgou E, Georgiou CD, Scopa CD, Thomopoulos KC.

Ann Hepatol. 2013 Mar-Apr;12(2):301-7.

14.

Stimulation of oval cell and hepatocyte proliferation by exogenous bombesin and neurotensin in partially hepatectomized rats.

Assimakopoulos SF, Tsamandas AC, Alexandris IH, Georgiou C, Vagianos CE, Scopa CD.

World J Gastrointest Pathophysiol. 2011 Dec 15;2(6):146-54. doi: 10.4291/wjgp.v2.i6.146.

15.

Altered expression of NFY-C and RORA in colorectal adenocarcinomas.

Kottorou AE, Antonacopoulou AG, Dimitrakopoulos FI, Tsamandas AC, Scopa CD, Petsas T, Kalofonos HP.

Acta Histochem. 2012 Oct;114(6):553-61. doi: 10.1016/j.acthis.2011.10.005. Epub 2011 Nov 21.

PMID:
22104449
16.

Altered intestinal tight junctions' expression in patients with liver cirrhosis: a pathogenetic mechanism of intestinal hyperpermeability.

Assimakopoulos SF, Tsamandas AC, Tsiaoussis GI, Karatza E, Triantos C, Vagianos CE, Spiliopoulou I, Kaltezioti V, Charonis A, Nikolopoulou VN, Scopa CD, Thomopoulos KC.

Eur J Clin Invest. 2012 Apr;42(4):439-46. doi: 10.1111/j.1365-2362.2011.02609.x. Epub 2011 Oct 24.

PMID:
22023490
17.

Evaluation of zotarolimus-eluting metal stent in animal ureters.

Kallidonis P, Kitrou P, Karnabatidis D, Kyriazis I, Kalogeropoulou C, Tsamandas A, Apostolopoulos DJ, Vrettos T, Liourdi D, Spiliopoulos S, Al-Aown A, Scopa CD, Liatsikos E.

J Endourol. 2011 Oct;25(10):1661-7. doi: 10.1089/end.2011.0308. Epub 2011 Sep 9.

PMID:
21905851
18.

Expression of the ribonucleases Drosha, Dicer, and Ago2 in colorectal carcinomas.

Papachristou DJ, Korpetinou A, Giannopoulou E, Antonacopoulou AG, Papadaki H, Grivas P, Scopa CD, Kalofonos HP.

Virchows Arch. 2011 Oct;459(4):431-40. doi: 10.1007/s00428-011-1119-5. Epub 2011 Jul 18.

PMID:
21769619
19.

The survivin -31 snp in human colorectal cancer correlates with survivin splice variant expression and improved overall survival.

Antonacopoulou AG, Floratou K, Bravou V, Kottorou A, Dimitrakopoulos FI, Marousi S, Stavropoulos M, Koutras AK, Scopa CD, Kalofonos HP.

Cell Oncol (Dordr). 2011 Aug;34(4):381-91. doi: 10.1007/s13402-011-0038-4. Epub 2011 May 3.

PMID:
21538024
20.

Complications and risk factors related to the extent of surgery in thyroidectomy. Results from 2,043 procedures.

Karamanakos SN, Markou KB, Panagopoulos K, Karavias D, Vagianos CE, Scopa CD, Fotopoulou V, Liava A, Vagenas K.

Hormones (Athens). 2010 Oct-Dec;9(4):318-25.

21.

The survivin -31 snp in human colorectal cancer correlates with survivin splice variant expression and improved overall survival.

Antonacopoulou AG, Floratou K, Bravou V, Kottorou A, Dimitrakopoulos FI, Marousi S, Stavropoulos M, Koutras AK, Scopa CD, Kalofonos HP.

Anal Cell Pathol (Amst). 2010;33(5):177-89. doi: 10.3233/ACP-CLO-2010-0537. Erratum in: Cell Oncol (Dordr), 2011 Aug;34(4):407-8.

22.

Intestinal epithelial cell proliferation, apoptosis and expression of tight junction proteins in patients with obstructive jaundice.

Assimakopoulos SF, Tsamandas AC, Louvros E, Vagianos CE, Nikolopoulou VN, Thomopoulos KC, Charonis A, Scopa CD.

Eur J Clin Invest. 2011 Feb;41(2):117-25. doi: 10.1111/j.1365-2362.2010.02379.x. Epub 2010 Sep 14.

PMID:
20840373
23.

Bombesin and neurotensin exert antiproliferative effects on oval cells and augment the regenerative response of the cholestatic rat liver.

Assimakopoulos SF, Tsamandas AC, Georgiou CD, Vagianos CE, Scopa CD.

Peptides. 2010 Dec;31(12):2294-303. doi: 10.1016/j.peptides.2010.09.003. Epub 2010 Sep 15.

PMID:
20833216
24.

Prion protein expression and the M129V polymorphism of the PRNP gene in patients with colorectal cancer.

Antonacopoulou AG, Palli M, Marousi S, Dimitrakopoulos FI, Kyriakopoulou U, Tsamandas AC, Scopa CD, Papavassiliou AG, Kalofonos HP.

Mol Carcinog. 2010 Jul;49(7):693-9. doi: 10.1002/mc.20642.

PMID:
20564346
25.

Integrin beta-3 L33P: a new insight into the pathogenesis of chronic oxaliplatin-induced peripheral neuropathy?

Antonacopoulou AG, Argyriou AA, Scopa CD, Kottorou A, Kominea A, Peroukides S, Kalofonos HP.

Eur J Neurol. 2010 Jul;17(7):963-8. doi: 10.1111/j.1468-1331.2010.02966.x. Epub 2010 Feb 23.

PMID:
20192979
26.

Histological comparison of autograft, allograft-DBM, xenograft, and synthetic grafts in a trabecular bone defect: an experimental study in rabbits.

Athanasiou VT, Papachristou DJ, Panagopoulos A, Saridis A, Scopa CD, Megas P.

Med Sci Monit. 2010 Jan;16(1):BR24-31.

PMID:
20037482
27.

The effect of different physical activity levels on muscle fiber size and type distribution of lumbar multifidus. A biopsy study on low back pain patient groups and healthy control subjects.

Mazis N, Papachristou DJ, Zouboulis P, Tyllianakis M, Scopa CD, Megas P.

Eur J Phys Rehabil Med. 2009 Dec;45(4):459-67. Epub 2009 Nov 5.

28.

Liability of the voltage-gated sodium channel gene SCN2A R19K polymorphism to oxaliplatin-induced peripheral neuropathy.

Argyriou AA, Antonacopoulou AG, Scopa CD, Kottorou A, Kominea A, Peroukides S, Kalofonos HP.

Oncology. 2009;77(3-4):254-6. doi: 10.1159/000236049. Epub 2009 Sep 7.

PMID:
19738391
29.

Histologic-type specific role of cell cycle regulators in non-small cell lung carcinoma.

Zolota VG, Tzelepi VN, Leotsinidis M, Zili PE, Panagopoulos ND, Dougenis D, Tsamandas AC, Scopa CD.

J Surg Res. 2010 Dec;164(2):256-65. doi: 10.1016/j.jss.2009.03.035. Epub 2009 May 4.

PMID:
19691991
30.

The potential role of Bcl-2 expression, apoptosis and cell proliferation (Ki-67 expression) in cases of gastric carcinoma and correlation with classic prognostic factors and patient outcome.

Tsamandas AC, Kardamakis D, Tsiamalos P, Liava A, Tzelepi V, Vassiliou V, Petsas T, Vagenas K, Zolota V, Scopa CD.

Anticancer Res. 2009 Feb;29(2):703-9.

31.

On the confounding role of administration solvents (vehicles) in animal experimental studies: Z-LLY-FMK or dimethyl sulfoxide (DMSO) attenuates intestinal apoptosis in bile duct-ligated rats?

Assimakopoulos SF, Scopa CD, Vagianos CE.

Dig Dis Sci. 2009 Dec;54(12):2767-8. doi: 10.1007/s10620-009-0712-9. No abstract available.

PMID:
19229616
32.

EGFR, HER-2 and COX-2 levels in colorectal cancer.

Antonacopoulou AG, Tsamandas AC, Petsas T, Liava A, Scopa CD, Papavassiliou AG, Kalofonos HP.

Histopathology. 2008 Dec;53(6):698-706.

PMID:
19102009
33.

Differential expression of dysadherin in papillary thyroid carcinoma and microcarcinoma: correlation with E-cadherin.

Batistatou A, Charalabopoulos K, Nakanishi Y, Vagianos C, Hirohashi S, Agnantis NJ, Scopa CD.

Endocr Pathol. 2008 Fall;19(3):197-202. doi: 10.1007/s12022-008-9035-1.

PMID:
18677652
34.

Pleiotropic effects of bombesin and neurotensin on intestinal mucosa: not just trefoil peptides.

Assimakopoulos SF, Scopa CD, Nikolopoulou VN, Vagianos CE.

World J Gastroenterol. 2008 Jun 14;14(22):3602-3.

35.

POLR2F, ATP6V0A1 and PRNP expression in colorectal cancer: new molecules with prognostic significance?

Antonacopoulou AG, Grivas PD, Skarlas L, Kalofonos M, Scopa CD, Kalofonos HP.

Anticancer Res. 2008 Mar-Apr;28(2B):1221-7.

36.

Pathogenesis and diagnostic significance of nuclear grooves in thyroid and other sites.

Batistatou A, Scopa CD.

Int J Surg Pathol. 2009 Apr;17(2):107-10. doi: 10.1177/1066896908316071. Epub 2008 May 14. Review.

PMID:
18480396
37.

Expression of cell cycle inhibitors p21, p27, p14 and p16 in gliomas. Correlation with classic prognostic factors and patients' outcome.

Zolota V, Tsamandas AC, Aroukatos P, Panagiotopoulos V, Maraziotis T, Poulos C, Scopa CD.

Neuropathology. 2008 Feb;28(1):35-42. doi: 10.1111/j.1440-1789.2007.00844.x.

PMID:
18181833
38.

Pathophysiology of increased intestinal permeability in obstructive jaundice.

Assimakopoulos SF, Scopa CD, Vagianos CE.

World J Gastroenterol. 2007 Dec 28;13(48):6458-64. Review.

39.

Application of paclitaxel-eluting metal stents in renal artery of pig model.

Voudoukis T, Liatsikos EN, Kagadis GC, Christeas N, Flaris N, Katsanos K, Costantinides C, Perimenis P, Scopa CD, Filos KS, Nikiforidis GC, Alexopoulos D, Siablis D.

J Endourol. 2007 Dec;21(12):1571-6.

PMID:
18044994
40.

Tight junctions in thyroid carcinogenesis: diverse expression of claudin-1, claudin-4, claudin-7 and occludin in thyroid neoplasms.

Tzelepi VN, Tsamandas AC, Vlotinou HD, Vagianos CE, Scopa CD.

Mod Pathol. 2008 Jan;21(1):22-30. Epub 2007 Oct 26.

41.

Effect of antioxidant treatments on the gut-liver axis oxidative status and function in bile duct-ligated rats.

Assimakopoulos SF, Maroulis I, Patsoukis N, Vagenas K, Scopa CD, Georgiou CD, Vagianos CE.

World J Surg. 2007 Oct;31(10):2023-32.

PMID:
17665241
42.

Bcl-2, bax and p53 expression in rectal adenocarcinoma. Correlation with classic pathologic prognostic factors and patients' outcome.

Tsamandas AC, Kardamakis D, Petsas T, Zolota V, Vassiliou V, Matatsoris T, Kalofonos H, Vagianos CE, Scopa CD.

In Vivo. 2007 Jan-Feb;21(1):113-8. Erratum in: In Vivo. 2007 May-Jun;21(3):553. Zolota, V [added]; Vassiliou, V [added]; Matatsoris, T [added]. In Vivo. 2007 Nov-Dec;21(6):1172.

43.

Histopathology of thyroid tumors. An overview.

Scopa CD.

Hormones (Athens). 2004 Apr-Jun;3(2):100-10. No abstract available.

44.

Evaluation of the prognostic and predictive value of p53 and Bcl-2 in breast cancer patients participating in a randomized study with dose-dense sequential adjuvant chemotherapy.

Malamou-Mitsi V, Gogas H, Dafni U, Bourli A, Fillipidis T, Sotiropoulou M, Vlachodimitropoulos D, Papadopoulos S, Tzaida O, Kafiri G, Kyriakou V, Markaki S, Papaspyrou I, Karagianni E, Pavlakis K, Toliou T, Scopa C, Papakostas P, Bafaloukos D, Christodoulou C, Fountzilas G.

Ann Oncol. 2006 Oct;17(10):1504-11. Epub 2006 Sep 12.

PMID:
16968874
45.

Images in pathology. A doggy face in an ugly neoplasm.

Scopa CD, Kourea HP.

Int J Surg Pathol. 2006 Jul;14(3):226. No abstract available.

PMID:
16959707
46.

Application of paclitaxel-eluting metal mesh stents within the pig ureter: an experimental study.

Liatsikos EN, Karnabatidis D, Kagadis GC, Rokkas K, Constantinides C, Christeas N, Flaris N, Voudoukis T, Scopa CD, Perimenis P, Filos KS, Nikiforidis GC, Stolzenburg JU, Siablis D.

Eur Urol. 2007 Jan;51(1):217-23. Epub 2006 Jun 14.

PMID:
16814926
47.

Experimental obstructive jaundice alters claudin-4 expression in intestinal mucosa: effect of bombesin and neurotensin.

Assimakopoulos SF, Vagianos CE, Charonis AS, Alexandris IH, Spiliopoulou I, Thomopoulos KC, Nikolopoulou VN, Scopa CD.

World J Gastroenterol. 2006 Jun 7;12(21):3410-5.

48.

Expression patterns of dysadherin and E-cadherin in lymph node metastases of colorectal carcinoma.

Batistatou A, Charalabopoulos AK, Scopa CD, Nakanishi Y, Kappas A, Hirohashi S, Agnantis NJ, Charalabopoulos K.

Virchows Arch. 2006 Jun;448(6):763-7. Epub 2006 Mar 29.

PMID:
16570180
49.

Evaluation of the prognostic value of HER-2 and VEGF in breast cancer patients participating in a randomized study with dose-dense sequential adjuvant chemotherapy.

Kostopoulos I, Arapantoni-Dadioti P, Gogas H, Papadopoulos S, Malamou-Mitsi V, Scopa CD, Markaki S, Karagianni E, Kyriakou V, Margariti A, Kyrkou E, Pavlakis K, Zaramboukas T, Skordalaki A, Bourli A, Markopoulos C, Pectasides D, Dimopoulos MA, Skarlos D, Fountzilas G.

Breast Cancer Res Treat. 2006 Apr;96(3):251-61.

PMID:
16538542
50.

Evaluation of margin status in lumpectomy specimens and residual breast carcinoma.

Scopa CD, Aroukatos P, Tsamandas AC, Aletra C.

Breast J. 2006 Mar-Apr;12(2):150-3.

PMID:
16509840

Supplemental Content

Loading ...
Support Center